HLB Pharmaceutical Co., Ltd. (KOSDAQ:047920)
South Korea · Delayed Price · Currency is KRW 6,510.00
-90.00 (-1.36%)
Sep 17, 2026, 3:30 PM KST
HLB Pharmaceutical Market Cap
HLB Pharmaceutical has a market cap or net worth of 213.52 billion as of September 17, 2026. Its market cap has increased by 6.26% in one year.
Market Cap
213.52B
Enterprise Value
214.33B
Revenue
251.95B
Ranking
n/a
PE Ratio
78.31
Stock Price
6,510.00
ChartMarket Cap Chart
Since December 21, 2015, HLB Pharmaceutical's market cap has increased from 84.28B to 213.52B, an increase of 153.35%. That is a compound annual growth rate of 9.03%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2026 | 213.52B | -5.20% |
| Dec 30, 2025 | 225.24B | -33.44% |
| Dec 30, 2024 | 338.42B | 58.45% |
| Dec 28, 2023 | 213.58B | 43.49% |
| Dec 29, 2022 | 148.85B | -21.48% |
| Dec 30, 2021 | 189.57B | -21.05% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Humedix | 265.23B |
| Korea United Pharm | 256.79B |
| Huons | 234.78B |
| Samjin Pharmaceuticals | 225.42B |
| Suheung | 224.39B |
| BNC KOREA | 193.22B |
| Yungjin Pharm. | 190.21B |
| Whan In Pharm | 188.35B |